Bentham Science Logo

Track Your Manuscript:

Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access


Current Cancer Drug Targets, Volume 20 - Number 10

Review Article

The Roles of Alternative Splicing in Tumor-immune Cell Interactions

, 20(10): 729 - 740

Yue Wang, Honglei Zhang*, Baowei Jiao*, Jianyun Nie*, Xiyin Li, Wenhuan Wang and Hairui Wang

DOI: 10.2174/1568009620666200619123725

Review Article

Tumor-Induced Metabolism and T Cells Located in Tumor Environment

, 20(10): 741 - 756

Sara Iranparast, Sanaz Tayebi, Fatemeh Ahmadpour and Bahman Yousefi*

DOI: 10.2174/1568009620666200720010647

Review Article

Regulation of Breast Cancer Progression by Noncoding RNAs

, 20(10): 757 - 767

Ravishkumar L. Akshaya, Muthukumar Rohini and Nagarajan Selvamurugan*

DOI: 10.2174/1568009620666200712144103

Review Article

Targeting NUPR1 for Cancer Treatment: A Risky Endeavor

, 20(10): 768 - 778

Salma M.A. Mansour, Sahar A. Ali, Shaira Nofal and Sameh H. Soror*

DOI: 10.2174/1568009620666200703152523

Review Article

Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling

, 20(10): 779 - 788

Wujun Zou*, Xiaoyan Hu and Liang Jiang

DOI: 10.2174/1568009620999200730183631

Review Article

Systematic Review Article

Prognostic Value of MiRNAs in Patients with Laryngeal Cancer: A Systematic Review and Meta-Analysis

, 20(10): 802 - 810

Wujun Zou, Xiaoyan Hu, Dingting Wang and Liang Jiang*

DOI: 10.2174/1568009620666200806094709

Clinical Trial

Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL

, 20(10): 811 - 817

Sven Nilsson, Alexander Stein, Christian Rolfo, Anne L. Kranich, Julia Mann, Konstantinos Papadimitriou, Susann Theile, Stefanie Amberg and Carsten Bokemeyer*

DOI: 10.2174/1568009620666200628105727


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog